Zidebactam (WCK-5107) is a dual-action small molecule that functions as both a beta-lactamase inhibitor and a penicillin-binding protein 2 (PBP2) inhibitor. It is utilized in research to study novel antibacterial strategies against multidrug-resistant Gram-negative pathogens, with demonstrated activity in both in vitro and in vivo experimental models.
